Abbott Libre 2 Continuous Glucose Monitor Owner’s Manual

: September 11, 2024
: Abbott

Table of Contents

Libre 2 Continuous Glucose Monitor
FreeStyle Libre
Specifications:
Product Usage Instructions:
Compatibility Check:
Registration Process:
Data Analysis:
Important Note:
- FAQ:
Q: Are the FreeStyle Libre 2 and FreeStyle Libre 3 apps
Q: Can the LibreView software be used as a substitute for

Libre 2 Continuous Glucose Monitor

“`html

FreeStyle Libre

Specifications:

Compatible with FreeStyle Libre 2 and FreeStyle Libre 3
apps
Intended for use by patients and healthcare professionals
Provides historical glucose meter data for diabetes
management
Requires registration with LibreView

Product Usage Instructions:

Compatibility Check:

Before using the FreeStyle Libre 2 or FreeStyle Libre 3 apps,
ensure compatibility with your mobile device and operating system
by checking the manufacturer’s website for detailed
information.

Registration Process:

To utilize the apps effectively, register with LibreView to
access and manage your glucose meter data. This step is essential
for both patients and healthcare professionals.

Data Analysis:

Use the FreeStyle Libre apps and LibreView software to review,
analyze, and evaluate historical glucose meter data. This
information is crucial in supporting effective diabetes
management.

Important Note:

The LibreView software is not intended to make treatment
decisions. Always consult healthcare professionals for medical
advice and treatment recommendations.

FAQ:

Q: Are the FreeStyle Libre 2 and FreeStyle Libre 3 apps

compatible with all mobile devices?

A: No, the apps are only compatible with specific mobile devices
and operating systems. Check the manufacturer’s website for a list
of compatible devices before use.

Q: Can the LibreView software be used as a substitute for

professional healthcare advice?

A: No, the LibreView software is not meant to replace
professional healthcare advice. It is designed to assist in glucose
data management but should not be used for treatment decisions.

“`

FreeStyle
Libre

Not actual patient data; for illustrative purposes only.
5 Steps to Better Follow-Up Appointments

Use this guide to support:

· Data interpretation

· Managing highs and lows

· Creating a joint action plan through collaborative decision-making

Abbott

life.to the

The FreeStyle Libre 2 app and FreeStyle Libre 3 app are only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app or the FreeStyle Libre 3 app may require registration with LibreView.

Abbott provides this information as a courtesy; it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors. Medicare coverage is available for FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third-party payor criteria apply.

The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

See Important Safety Information on last page.

1

1 Learn from data on the reader or app
There are valuable reports within the reader and app including: · Ambulatory Glucose Profile (AGP) · Glucose Pattern Insights (GPI) · Time in Target · Glucose Management Indicator (GMI)

TIME IN TARGET January 3-16, 2024

Time In Target
3% Above
In Target Below Target Range 70-180 mg/dL
Last 14 Days
FreeStyle Libre 3
Abbott

Above Target Range (>180 mg/dL)
Target Glucose Range (70-180 mg/dL)
Below Target Range (<70 mg/dL)
Every 10% increase in time in range = ~0.8% decrease in A1c1

181-240 3%

Target Range: 70 – 180 mg/dL
for Data available 14 of 14 days
@

14 DAYS

30 DAYS

90 DAYS

Not actual patient data; for illustrative purposes only.
The Time in Target report can help you: · Understand how long you spend in each glucose range at a glance · See how food, medication, and activities cause your blood glucose levels to rise and fall

2 Share data with a healthcare professional using LibreView§

LibreView makes it easy to share§ a full glycemic picture for more informed treatment decisions.
Getting started is easy:
· For Healthcare Professional: Add the patient’s email to the office’s LibreView patient list OR
· For Patient: Connect the Practice ID in the Linked Practices on the patient’s LibreView account
Add Practice ID here

Abbott provides this information as a courtesy; it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors. Medicare coverage is available for FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third-party payor criteria apply.

*The FreeStyle Libre 2 app and FreeStyle Libre 3 app are only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app or the FreeStyle Libre 3 app may require registration with LibreView. The glucose management indicator report is
only available on the FreeStyle Libre system apps. The FreeStyle Libre 2 and FreeStyle Libre 3 apps and the FreeStyle Libre 2 and FreeStyle Libre 3 readers have similar but not identical
features. Fingersticks are required for treatment decisions when you see the Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations. The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare
professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice. §The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to
transfer to connected LibreLinkUp app users.

1. Vigersky, R. Diabetes Technology and Therapeutics (2019): https://doi.org/10.1089/dia.2018.0310.

See Important Safety Information on last page.

2

3 Identify glucose trends and patterns with reports
The LibreView* GPI Report can help you identify what may be causing the highs and lows in your glucose levels by trending your data over a 14-day window.

Glucose Patterns (14 Days)
Highs with some Lows

with some Lows

250

Target Range

54

1

12AM

3

6

9

12PM

3

6

Not actual patient data; for illustrative purposes only.

9

12AM

Factors to consider:
Medications: · Avoid skipping, delaying, or missing doses
Exercise: · Engage in both anaerobic and aerobic
activities, record the timing and duration of workouts, and notice any specific patterns
Sleep quality: · Observe sleep schedule and patterns
and note if experiencing any changes in glucose levels

Meals:
© · Note when meals are typically eaten, the size of meals, alcohol consumption, and skipped meals
Shift work: · Watch when you usually sleep, and if sleep
schedules change based on work shifts
Additional areas needing help: Q&A · Identify the areas with the most variability
that could be crucial for improvement

*The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

See Important Safety Information on last page.

3

4 Harness these insights for collaborative decision-making
Try an EASY framework to help control your glucose levels using actionable insights. You can customize each of these for your visit. Create an EASY framework · Engage with the data · Adjust plan to improve patterns and time in range · Set achievable goals and celebrate milestones · You can be at the center of personalized healthcare

5 Stay on track

Not actual patient data; for illustrative purposes only.

Monitor your time in range and remember to complete A1c testing at least semiannually, or quarterly if not meeting glycemic targets1.

LibreLinkUp
Share data with your caregivers through the LibreLinkUp* app. It can be invaluable in helping
to achieve goals.

Take notes in the app, and schedule your next appointment.
Keep the momentum going to ensure you stay on track.

We’re in this together to make diabetes management better for you.

By FreeStyle Libre

| Abbott
the

Abbott provides this information as a courtesy; it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors. Medicare coverage is available for FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third-party payor criteria apply.
*The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of the LibreLinkUp app requires registration with LibreView. LibreLinkUp is not intended to be used for dosing decisions. The user should follow instructions on the continuous glucose monitoring system. LibreLinkUp is not intended to replace self-monitoring practices as advised by a physician. The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users. The FreeStyle Libre 2 app and FreeStyle Libre 3 app are only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app or the FreeStyle Libre 3 app may require registration with LibreView.
1. American Diabetes Association. “Glycemic Goals and Hypoglycemia: Standards of Medical Care in Diabetes2024.” Diabetes Care 47(suppl 1)(December 2024): S111-S125. https://doi.org/10.2337/dc24-S006.

IMPORTANT SAFETY INFORMATION

FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or https://www.freestyle.abbott/us-en/safety-information.html for safety info.

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott.

4